Skip to main navigation Skip to search Skip to main content

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

  • Arif B. Ekici
  • , Arndt Hartmann
  • , Matthias W. Beckmann
  • , Jaana M. Hartikainen
  • , Veli-Matti Kosma
  • , Vesa Kataja
  • , Arja Jukkola-Vuorinen
  • , Katri Pylkäs
  • , Saila Kauppila
  • , Aida Karina Dieffenbach
  • , Christa Stegmaier
  • , Volker Arndt
  • , Sara Margolin
  • , Jose Ignacio Arias Perez
  • , M. Pilar Zamora
  • , Alan Ashworth
  • , Michael Jones
  • , Nick Orr
  • , Patrick Arveux
  • , Pierre Kerbrat
  • Thérèse Truong, Peter Bugert, Amanda E. Toland, Christine B. Ambrosone, France Labrèche, Mark S. Goldberg, Martine Dumont, Argyrios Ziogas, Gillian S. Dite, Carmel Apicella, Melissa C. Southey, Jirong Long, Martha Shrubsole, Sandra Deming-Halverson, Filomena Ficarazzi, Monica Barile, Paolo Peterlongo, Katarzyna Durda, Katarzyna Jaworska-Bieniek, Robert A. E. M. Tollenaar, Caroline Seynaeve, Thomas Brüning, Yon-Dschun Ko, Carolien H.M. Van Deurzen, John W. M. Martens, Mieke Kriege, Jonine D. Figueroa, Stephen J. Chanock, Jolanta Lissowska, Ian Tomlinson, Andreas Schneeweiss, William J. Tapper, Susan M. Gerty, Lorraine Durcan, Catriona McLean, Roger L. Milne, Laura Baglietto, Isabel Dos Santos Silva, Olivia Fletcher, Nichola Johnson, Laura J. Van'T Veer, Sten Cornelissen, Asta Försti, Diana Torres, Thomas Rüdiger, Anja Rudolph, Dieter Flesch-Janys, Stefan Nickels, Caroline Weltens, Giuseppe Floris, Matthieu Moisse, Joe Dennis, Qin Wang, Alison M. Dunning, Mitul Shah, Judith Brown, Jacques Simard, Hoda Anton-Culver, Susan L. Neuhausen, John L. Hopper, Natalia Bogdanova, Thilo Dörk, Wei Zheng, Paolo Radice, Anna Jakubowska, Jan Lubinski, Peter Devillee, Hiltrud Brauch, Maartje Hooning, Montserrat García-Closas, Elinor Sawyer, Barbara Burwinkel, Frederick Marmee, Diana M. Eccles, Graham G. Giles, Julian Peto, Marjanka Schmidt, Annegien Broeks, Ute Hamann, Jenny Chang-Claude, Diether Lambrechts, Paul D.P. Pharoah, Douglas Easton, V. Shane Pankratz, Susan Slager, Celine M. Vachon, Fergus J. Couch
  • Institute of Pathology
  • Medical Faculty of the University of Bonn
  • Institute for Occupational Medicine and Maritime Medicine
  • University Medical Center Hamburg-Eppendorf
  • University of Tübingen
  • Westmead Millennium Institute
  • Peter MacCallum Cancer Institute
  • Molecular Genetics of Breast Cancer
  • German Cancer Research Center
  • Ruhr-Universität Bochum
  • Department of Internal Medicine
  • Johanniter Krankenhaus
  • Mayo Clinic
  • Wayne State University School of Medicine
  • Centre for Cancer Genetic Epidemiology
  • Department of Medical Epidemiology and Biostatistics
  • University of Helsinki
  • Gentofte University Hospital
  • Mount Sinai Hospital, Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute
  • University of Toronto
  • University of Sheffield
  • University of Heidelberg
  • University of California, Irvine
  • Institute of Biosciences and Applications
  • Keck School of Medicine of USC
  • University Hospital Erlangen
  • McGill University
  • University of Eastern Finland
  • Imaging Center
  • University of Oulu
  • Division of Clinical Epidemiology and Aging Research
  • Department of Molecular Medicine and Surgery
  • QIMR Berghofer Medical Research Institute
  • Cell Division and Cancer Group
  • CIBERER Spanish Network for Rare Diseases
  • Divisions of Molecular Pathology and Cancer Therapeutics
  • Faculty of Medicine
  • University of Oslo
  • National Institutes of Health (NIH)
  • Hormones and Women's Health Team
  • Technical University Munich
  • University of Toronto Faculty of Medicine
  • University Health Network
  • Prosserman Centre for Health Research
  • University of Toronto/Lunenfeld-Tanenbaum Research Institute
  • A*STAR
  • Hunter Area Pathology Service
  • La Paz University Hospital
  • Aristotle University of Thessaloniki
  • The University of Hawaii Cancer Center
  • Galway University Hospital
  • Kuopio University Hospital
  • University Hospital of Oulu
  • Saarland Cancer Registry
  • Karolinska Institutet
  • National Breast Cancer Foundation Cancer
  • Faculty of Pharmacy
  • McGill University Health Centre, Royal Victoria Hospital
  • McGill University
  • Hospital Monte Naranco
  • Centre Georges-François Leclerc
  • Centre Eugène Marquis Rennes
  • German Red Cross Blood Service of Baden-Wurttemberg-Hessen
  • Heidelberg University
  • Ohio State University
  • Roswell Park Cancer Institute
  • Université de Montréal
  • Centre hospitalier universitaire de Québec
  • Melbourne School of Population and Global Health
  • University of Melbourne
  • Vanderbilt-Ingram Cancer Center
  • Cogentech Cancer Genetic Test Laboratory
  • IFOM - The FIRC Institute of Molecular Oncology
  • Department of Experimental Oncology
  • University
  • Leiden University Medical Center
  • Erasmus MC
  • Molecular Genetics of Breast Cancer
  • Institute for Prevention and Occupational Medicine of the German Social Accident Insurance
  • University of Bonn
  • University of Southampton, Faculty of Medicine
  • Alfred Hospital
  • Cancer Council Victoria
  • London School of Hygiene and Tropical Medicine
  • Antoni Van Leeuwenhoek Hospital
  • Division of Molecular Genetic Epidemiology
  • Lund University
  • Pontificia Universidad Javeriana
  • Städtisches Klinikum Karlsruhe
  • Division of Cancer Epidemiology
  • KU Leuven– University Hospital Leuven
  • University of Leuven
  • VIB Center for the Biology of Disease
  • University of Cambridge
  • City of Hope National Med Center
  • Hannover Medical School
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
  • Guy's Hospital

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

12 Citations (Scopus)

Abstract

Mitotic index is an important component of histologic grade and has an etiologic role in breast tumorigenesis. Several small candidate gene studies have reported associations between variation in mitotic genes and breast cancer risk. We measured associations between 2156 single nucleotide polymorphisms (SNPs) from 194 mitotic genes and breast cancer risk, overall and by histologic grade, in the Breast Cancer Association Consortium (BCAC) iCOGS study (n = 39067 cases; n = 42 106 controls). SNPs in TACC2 [rs17550038: odds ratio (OR) = 1.24, 95% confidence interval (CI) 1.16-1.33, P = 4.2 × 10-10)and EIF3H(rs799890: OR = 1.07, 95% C11.041.11, P = 8.7 × 10-6) were significantly associated with risk of low-grade breast cancer. The TACC2signal was retained (rs17550038: OR = 1.15, 95% C11.07-1.23, P = 7.9 × 10-5) after adjustment for breast cancer risk SNPs in the nearby FGFR2gene, suggesting that TACC2 is a novel, independent genome-wide significant genetic risk locus for low-grade breast cancer. While no SNPs were individually associated with high-grade disease, a pathway-level gene set analysis showed that variation across the 194 mitotic genes was associated with high-grade breast cancer risk(P = 2.1 × 10-3). These observations will provide insight into the contribution of mitotic defects to histological grade and the etiology of breast cancer.

Original languageEnglish
Pages (from-to)6034-6046
Number of pages13
JournalHuman Molecular Genetics
Volume23
Issue number22
DOIs
Publication statusPublished - 15 Nov 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade'. Together they form a unique fingerprint.

Cite this